Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1982-10-12
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0043-5147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6287740-Aged,
pubmed-meshheading:6287740-Arteriosclerosis,
pubmed-meshheading:6287740-Humans,
pubmed-meshheading:6287740-Middle Aged,
pubmed-meshheading:6287740-Neurocirculatory Asthenia,
pubmed-meshheading:6287740-Propanolamines,
pubmed-meshheading:6287740-Suloctidil,
pubmed-meshheading:6287740-Syndrome
|
pubmed:year |
1982
|
pubmed:articleTitle |
[Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
|
pubmed:publicationType |
Journal Article,
English Abstract
|